South Korean drugmaker Boryung Pharmaceutical reached an agreement with Zuellig Pharma distributor Zanovex to sell its anti-hypertensive combination drugs Dukarb, or fimasartan/amlodipine, and Tuvero, or fimasartan/rosuvastatin, in Southeast Asian countries.
Boryung Pharma to market blood pressure combo drugs in Southeast Asia
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.